作者
ML Bertolaccini, O Amengual, T Atsumi, Walter L Binder, B de Laat, R Forastiero, WH Kutteh, M Lambert, H Matsubayashi, V Murthy, M Petri, Jacob H Rand, M Sanmarco, AE Tebo, SS Pierangeli
发表日期
2011/2
期刊
Lupus
卷号
20
期号
2
页码范围
191-205
出版商
SAGE Publications
简介
Current classification criteria for definite APS recommend the use of one or more of three positive standardized laboratory assays, including anticardiolipin antibodies (aCL), lupus anticoagulant (LA), and antibodies directed to β2glycoprotein I (anti-β2GPI) to detect antiphospholipid antibodies (aPL) in the presence of at least one of the two major clinical manifestations (i.e., thrombosis or pregnancy morbidity) of the syndrome. Several other autoantibodies shown to be directed to phospholipids and/or their complexes with phospholipids and/or to proteins of the coagulation cascade, as well as a mechanistic test for resistance to annexin A5 anticoagulant activity, have been proposed to be relevant to APS. A task force of worldwide scientists in the field discussed and analyzed critical questions related to ‘non-criteria’ aPL tests in an evidence-based manner during the 13th International Congress on Antiphospholipid …
引用总数
20102011201220132014201520162017201820192020202120222023202413171318201121819161011113